Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy.
Fine HA. Fine HA. Neurol Clin. 1995 Nov;13(4):827-46. Neurol Clin. 1995. PMID: 8583999 Review.
Antiangiogenic therapy for primary and metastatic brain tumors.
Purow B, Fine HA. Purow B, et al. Among authors: fine ha. Hematol Oncol Clin North Am. 2004 Oct;18(5):1161-81, x. doi: 10.1016/j.hoc.2004.05.003. Hematol Oncol Clin North Am. 2004. PMID: 15474340 Review.
Malignant gliomas: new translational therapies.
Sul J, Fine HA. Sul J, et al. Among authors: fine ha. Mt Sinai J Med. 2010 Nov-Dec;77(6):655-66. doi: 10.1002/msj.20223. Mt Sinai J Med. 2010. PMID: 21105127 Free PMC article. Review.
Promising new therapies for malignant gliomas.
Fine HA. Fine HA. Cancer J. 2007 Nov-Dec;13(6):349-54. doi: 10.1097/PPO.0b013e31815b18db. Cancer J. 2007. PMID: 18032970 Review.
Bevacizumab for malignant gliomas.
Iwamoto FM, Fine HA. Iwamoto FM, et al. Among authors: fine ha. Arch Neurol. 2010 Mar;67(3):285-8. doi: 10.1001/archneurol.2010.11. Arch Neurol. 2010. PMID: 20212225 Free PMC article. Review.
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD. Wen PY, et al. Among authors: fine ha. Clin Cancer Res. 2006 Aug 15;12(16):4899-907. doi: 10.1158/1078-0432.CCR-06-0773. Clin Cancer Res. 2006. PMID: 16914578 Clinical Trial.
A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.
Fine HA, Wen PY, Robertson M, O'Neill A, Kowal J, Loeffler JS, Black PM. Fine HA, et al. Clin Cancer Res. 1997 Mar;3(3):381-7. Clin Cancer Res. 1997. PMID: 9815695 Clinical Trial.
Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T, Cao Y, Folkman J, Fine HA. Tanaka T, et al. Among authors: fine ha. Cancer Res. 1998 Aug 1;58(15):3362-9. Cancer Res. 1998. PMID: 9699667
Immune parameters affecting adenoviral vector gene therapy in the brain.
Parr MJ, Wen PY, Schaub M, Khoury SJ, Sayegh MH, Fine HA. Parr MJ, et al. Among authors: fine ha. J Neurovirol. 1998 Apr;4(2):194-203. doi: 10.3109/13550289809114519. J Neurovirol. 1998. PMID: 9584956
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.
Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin WG Jr, Fine HA. Parr MJ, et al. Among authors: fine ha. Nat Med. 1997 Oct;3(10):1145-9. doi: 10.1038/nm1097-1145. Nat Med. 1997. PMID: 9334729
194 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback